CD154 blockade effectively controls antibody-mediated rejection in highly sensitized nonhuman primate kidney transplant recipients.
Anwar IJ, DeLaura I, Ladowski JM, Schilirò D, Gao Q, Manook M, Yoon J, Belloni R, Park A, Schuster DJ, Song M, Lin L, Farris AB, Magnani D, Williams K, Kwun J, Knechtle SJ.
Anwar IJ, et al. Among authors: lin l.
Sci Transl Med. 2025 Jan;17(779):eadn8130. doi: 10.1126/scitranslmed.adn8130. Epub 2025 Jan 1.
Sci Transl Med. 2025.
PMID: 39742504